Latest News about MCRB

Recent news which mentions MCRB

< Previous 1 2 3 4 Next >

Seres Therapeutics Ditches Its SER-301 Phase 1b Second Study In Ulcerative Colitis

April 07, 2022

Seres Therapeutics' SER-155 Reduces Infection, GvHD In Animal Study

March 18, 2022

Seres Therapeutics Earnings Perspective: Return On Capital Employed

March 08, 2022

Seres Therapeutics: Q4 Earnings Insights

March 01, 2022

Earnings Scheduled For March 1, 2022

March 01, 2022

Earnings Preview: Seres Therapeutics

February 28, 2022

Seres Therapeutics' Oral Microbiome Candidate Shows Meaningful Improvements In Difficile Infection

January 20, 2022

Seres Posts Interim Microbiome Data Analysis From Failed Ulcerative Colitis Study

December 16, 2021

Jim Cramer Shares His Thoughts On Novavax, ViacomCBS And More

December 06, 2021

52 Biggest Movers From Yesterday

December 01, 2021

Why Shares of Seres Therapeutics Rose More Than 21% on Tuesday

November 30, 2021

35 Stocks Moving In Tuesday's Mid-Day Session

November 30, 2021

Looking Into Seres Therapeutics's Return On Capital Employed

November 11, 2021

76 Biggest Movers From Yesterday

November 11, 2021

Why Shares of Seres Therapeutics Are Up More Than 22% Wednesday

November 10, 2021

Mid-Afternoon Market Update: Nasdaq Tumbles 300 Points; PubMatic Shares Gain After Q3 Results

November 10, 2021

12 Health Care Stocks Moving In Wednesday's Intraday Session

November 10, 2021

Mid-Morning Market Update: Markets Edge Lower; US Inflation Rate Increases To 6.2%

November 10, 2021

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

November 10, 2021

53 Biggest Movers From Yesterday

September 16, 2021

Why Seres Therapeutics Stock Is Soaring Today

September 15, 2021

Why Seres Therapeutics Shares Are Trading Higher Today

September 15, 2021

12 Health Care Stocks Moving In Wednesday's Intraday Session

September 15, 2021

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs

September 15, 2021

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout

September 14, 2021

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test

September 10, 2021

Stocks That Hit 52-Week Lows On Friday

August 27, 2021

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

August 20, 2021

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline

August 18, 2021

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

August 17, 2021

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.